X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (327) 327
postremission therapy (282) 282
hematology (260) 260
adult (234) 234
middle aged (233) 233
female (222) 222
male (221) 221
acute myelogenous leukemia (209) 209
oncology (206) 206
index medicus (170) 170
adolescent (156) 156
remission induction (142) 142
treatment outcome (140) 140
aged (137) 137
leukemia, myeloid, acute - therapy (118) 118
acute myeloid-leukemia (115) 115
antineoplastic combined chemotherapy protocols - therapeutic use (115) 115
acute myeloid leukemia (113) 113
bone-marrow-transplantation (111) 111
leukemia, myeloid, acute - mortality (108) 108
disease-free survival (104) 104
prognosis (100) 100
transplantation (96) 96
chemotherapy (95) 95
stem-cell transplantation (89) 89
intensive chemotherapy (87) 87
leukemia, myeloid, acute - drug therapy (87) 87
acute disease (82) 82
postremission chemotherapy (80) 80
aml (79) 79
survival analysis (79) 79
high-dose cytarabine (78) 78
transplantation, homologous (77) 77
acute nonlymphocytic leukemia (75) 75
cytarabine - administration & dosage (75) 75
retrospective studies (70) 70
young adult (70) 70
leukemia, myeloid, acute - genetics (67) 67
1st complete remission (63) 63
hematopoietic stem cell transplantation (63) 63
survival rate (60) 60
adults (55) 55
cancer (55) 55
group-b (52) 52
recurrence (52) 52
leukemia, myeloid - drug therapy (50) 50
risk factors (49) 49
stem cells (49) 49
transplantation, autologous (49) 49
1st remission (48) 48
bone-marrow transplantation (48) 48
immunology (48) 48
hematopoietic stem cells (47) 47
adult patients (46) 46
cytosine-arabinoside (44) 44
aged, 80 and over (43) 43
cytogenetics (43) 43
follow-up studies (42) 42
daunorubicin (40) 40
cytarabine - therapeutic use (39) 39
hematology, oncology and palliative medicine (39) 39
colony-stimulating factor (38) 38
leukemia, myeloid - therapy (37) 37
leukemia (36) 36
survival (36) 36
cytarabine (35) 35
hematopoietic stem cell transplantation - methods (35) 35
minimal residual disease (35) 35
older patients (35) 35
antineoplastic agents - therapeutic use (34) 34
bone marrow transplantation (34) 34
combined modality therapy (34) 34
age factors (33) 33
leukemia, myeloid - mortality (33) 33
remission (33) 33
research (32) 32
therapy (32) 32
trial (32) 32
acute myeloblastic-leukemia (31) 31
karyotyping (31) 31
relapse (31) 31
child (30) 30
daunorubicin - administration & dosage (29) 29
leukemia, myeloid, acute - pathology (29) 29
analysis (28) 28
antineoplastic combined chemotherapy protocols - administration & dosage (28) 28
antineoplastic combined chemotherapy protocols - adverse effects (28) 28
prospective studies (28) 28
acute myelocytic-leukemia (27) 27
consolidation therapy (27) 27
induction (27) 27
acute promyelocytic leukemia (26) 26
chromosome aberrations (26) 26
consolidation chemotherapy (26) 26
acute lymphoblastic-leukemia (25) 25
kaplan-meier estimate (25) 25
etoposide - administration & dosage (24) 24
myelodysplastic syndrome (24) 24
abridged index medicus (23) 23
leukemia, myeloid, acute - diagnosis (23) 23
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Seminars in Hematology, ISSN 0037-1963, 04/2019, Volume 56, Issue 2, pp. 96 - 101
Intensive induction chemotherapy followed by postremission treatment with either high-dose cytarabine-based regimens, autologous or allogeneic hematopoietic... 
YOUNGER PATIENTS | ADULT PATIENTS | GEMTUZUMAB OZOGAMICIN | POSTREMISSION THERAPY | IDH2 MUTATIONS | OLDER PATIENTS | HIGH-DOSE CYTARABINE | PROGNOSTIC RELEVANCE | ACUTE MYELOID-LEUKEMIA | HEMATOLOGY | MINIMAL RESIDUAL DISEASE
Journal Article
Annals of Hematology, ISSN 0939-5555, 1/2014, Volume 93, Issue 1, pp. 47 - 55
Journal Article
Annals of Hematology, ISSN 0939-5555, 2012, Volume 91, Issue 6, pp. 825 - 835
Journal Article
Journal Article
BLOOD, ISSN 0006-4971, 09/2019, Volume 132, Issue 12, pp. 935 - 945
We designed a trial in which postremission therapy of young patients with de novo acute myeloid leukemia (AML) was decided combining cytogenetics/genetics and... 
AML | POSTREMISSION THERAPY | MANAGEMENT | HEMATOPOIETIC-CELL TRANSPLANTATION | STANDARD-RISK | RECOMMENDATIONS | CLASSIFICATION | PROGNOSTIC RELEVANCE | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | STRATIFICATION
Journal Article
Annals of Hematology, ISSN 0939-5555, 6/2004, Volume 83, Issue 6, pp. 336 - 344
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2006, Volume 12, Issue 1, pp. 1 - 30
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 11, pp. 1027 - 1036
Journal Article